TapewireFind a company

organization · Reporting owner

LILLY ENDOWMENT INC

Disclosed activity across 1 company

Tapewire entity
10861
SEC CIK
0000316011

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

No relationships currently tracked through insider filings.

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

No balances currently tracked through insider filings.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

ELI LILLY & Co

Report date May 06, 2026 · Filed May 07, 2026

Section 16 reporting ended · disclosed 2026-05-07. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect91,881,150 Ending reported balance After 2026-05-06 transaction · row 2
2 source rows · reconciled sequence

Row 1 · 2026-05-06 · Sale · Disposed 13,620 · Balance 91,883,358

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $995.00 to $995.9963, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) and (2) to this Form 4.

Row 2 · 2026-05-06 · Sale · Disposed 2,208 · Balance 91,881,150

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $996.00 to $996.46, inclusive.

Filing footnotes · ownership attribution and instrument terms

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $995.00 to $995.9963, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) and (2) to this Form 4.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $996.00 to $996.46, inclusive.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
January 10, 2024 Filed Jan 11, 2024 21:05 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 802 $633.52 $508,079.03
Disclosure

SEC source: 0001415889-24-000980 · form4-01112024_040101.xml · nonDerivative · entry 4

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,559,854

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $633.075 to $633.9375, inclusive.

Read SEC document
January 10, 2024 Filed Jan 11, 2024 21:05 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 9,098 $632.17 $5,751,491.76
Disclosure

SEC source: 0001415889-24-000980 · form4-01112024_040101.xml · nonDerivative · entry 3

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,560,656

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $632.00 to $632.36, inclusive.

Read SEC document
January 10, 2024 Filed Jan 11, 2024 21:05 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 21,503 $631.38 $13,576,521.13
Disclosure

SEC source: 0001415889-24-000980 · form4-01112024_040101.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,569,754

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $631.00 to $631.9875, inclusive.

Read SEC document
January 10, 2024 Filed Jan 11, 2024 21:05 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 128,627 $630.19 $81,059,449.13
Disclosure

SEC source: 0001415889-24-000980 · form4-01112024_040101.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,591,257

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $630.00 to $630.995, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6) and (7) to this Form 4.

Read SEC document
January 09, 2024 Filed Jan 10, 2024 21:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 3,491 $633.41 $2,211,234.31
Disclosure

SEC source: 0001415889-24-000904 · form4-01102024_040102.xml · nonDerivative · entry 4

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,719,884

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $633.20 to $633.745, inclusive.

Read SEC document
January 09, 2024 Filed Jan 10, 2024 21:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 14,566 $632.52 $9,213,300.89
Disclosure

SEC source: 0001415889-24-000904 · form4-01102024_040102.xml · nonDerivative · entry 3

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,723,375

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $632.18 to $633.125, inclusive.

Read SEC document
January 09, 2024 Filed Jan 10, 2024 21:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 5,608 $631.72 $3,542,657.72
Disclosure

SEC source: 0001415889-24-000904 · form4-01102024_040102.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,737,941

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $631.155 to $632.15, inclusive.

Read SEC document
January 09, 2024 Filed Jan 10, 2024 21:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 10,873 $630.39 $6,854,219.60
Disclosure

SEC source: 0001415889-24-000904 · form4-01102024_040102.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,743,549

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $630.00 to $630.97, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), and (4) to this Form 4.

Read SEC document
January 04, 2024 Filed Jan 5, 2024 19:15 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 700 $631.07 $441,747.60
Disclosure

SEC source: 0001415889-24-000758 · form4-01052024_070143.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,754,422

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $631.035 to $631.145, inclusive.

Read SEC document
January 04, 2024 Filed Jan 5, 2024 19:15 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 13,688 $630.24 $8,626,697.74
Disclosure

SEC source: 0001415889-24-000758 · form4-01052024_070143.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,755,122

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $630.00 to $630.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.

Read SEC document
October 11, 2023 Filed Oct 12, 2023 20:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 21,122 $607.74 $12,836,747.65
Disclosure

SEC source: 0001415889-23-014136 · form4-10122023_041001.xml · nonDerivative · entry 5

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,768,810

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $607.3698 to $608.20, inclusive.

Read SEC document
October 11, 2023 Filed Oct 12, 2023 20:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 51,998 $606.75 $31,549,630.51
Disclosure

SEC source: 0001415889-23-014136 · form4-10122023_041001.xml · nonDerivative · entry 4

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,789,932

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $606.31 to $607.27, inclusive.

Read SEC document
October 11, 2023 Filed Oct 12, 2023 20:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 74,203 $605.41 $44,923,386.64
Disclosure

SEC source: 0001415889-23-014136 · form4-10122023_041001.xml · nonDerivative · entry 3

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,841,930

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $605.27 to $606.1522, inclusive.

Read SEC document
October 11, 2023 Filed Oct 12, 2023 20:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 29,842 $604.40 $18,036,415.27
Disclosure

SEC source: 0001415889-23-014136 · form4-10122023_041001.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,916,133

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $604.00 to $604.94, inclusive.

Read SEC document
October 11, 2023 Filed Oct 12, 2023 20:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 37,835 $603.24 $22,823,698.91
Disclosure

SEC source: 0001415889-23-014136 · form4-10122023_041001.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,945,975

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $603.00 to $603.94, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), and (5) to this Form 4.

Read SEC document
September 07, 2023 Filed Sep 8, 2023 20:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 3,500 $575.37 $2,013,802.00
Disclosure

SEC source: 0001415889-23-013115 · form4-09082023_040901.xml · nonDerivative · entry 11

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,983,810

F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $574.90 to $575.88, inclusive.

Read SEC document
September 07, 2023 Filed Sep 8, 2023 20:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 11,335 $574.28 $6,509,463.80
Disclosure

SEC source: 0001415889-23-013115 · form4-09082023_040901.xml · nonDerivative · entry 10

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,987,310

F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.89 to $574.86, inclusive.

Read SEC document
September 07, 2023 Filed Sep 8, 2023 20:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 46,428 $573.34 $26,618,797.38
Disclosure

SEC source: 0001415889-23-013115 · form4-09082023_040901.xml · nonDerivative · entry 9

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,998,645

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.89 to $573.88, inclusive.

Read SEC document
September 07, 2023 Filed Sep 8, 2023 20:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 60,926 $572.36 $34,871,422.58
Disclosure

SEC source: 0001415889-23-013115 · form4-09082023_040901.xml · nonDerivative · entry 8

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,045,073

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.89 to $572.88, inclusive.

Read SEC document
September 07, 2023 Filed Sep 8, 2023 20:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 27,849 $571.66 $15,920,047.94
Disclosure

SEC source: 0001415889-23-013115 · form4-09082023_040901.xml · nonDerivative · entry 7

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,105,999

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.89 to $571.885, inclusive.

Read SEC document
September 07, 2023 Filed Sep 8, 2023 20:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 10,412 $570.05 $5,935,329.36
Disclosure

SEC source: 0001415889-23-013115 · form4-09082023_040901.xml · nonDerivative · entry 6

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,133,848

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $569.58 to $570.57, inclusive.

Read SEC document
September 07, 2023 Filed Sep 8, 2023 20:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 15,258 $568.89 $8,680,184.65
Disclosure

SEC source: 0001415889-23-013115 · form4-09082023_040901.xml · nonDerivative · entry 5

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,144,260

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $568.55 to $569.35, inclusive.

Read SEC document
September 07, 2023 Filed Sep 8, 2023 20:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 14,978 $568.09 $8,508,896.95
Disclosure

SEC source: 0001415889-23-013115 · form4-09082023_040901.xml · nonDerivative · entry 4

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,159,518

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $567.55 to $568.54, inclusive.

Read SEC document
September 07, 2023 Filed Sep 8, 2023 20:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 7,382 $567.19 $4,186,959.67
Disclosure

SEC source: 0001415889-23-013115 · form4-09082023_040901.xml · nonDerivative · entry 3

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,174,496

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $566.53 to $567.495, inclusive.

Read SEC document
September 07, 2023 Filed Sep 8, 2023 20:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 7,732 $566.06 $4,376,799.12
Disclosure

SEC source: 0001415889-23-013115 · form4-09082023_040901.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,181,878

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $565.53 to $566.525, inclusive.

Read SEC document
September 07, 2023 Filed Sep 8, 2023 20:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 4,200 $565.14 $2,373,571.20
Disclosure

SEC source: 0001415889-23-013115 · form4-09082023_040901.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,189,610

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $564.50 to $565.49, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), (8), (9), (10), and (11) to this Form 4.

Read SEC document
August 31, 2023 Filed Sep 1, 2023 20:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 900 $557.19 $501,473.70
Disclosure

SEC source: 0001415889-23-012859 · form4-09012023_040902.xml · nonDerivative · entry 4

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,193,810

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $557.03 to $557.37, inclusive.

Read SEC document
August 31, 2023 Filed Sep 1, 2023 20:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 4,441 $556.58 $2,471,776.22
Disclosure

SEC source: 0001415889-23-012859 · form4-09012023_040902.xml · nonDerivative · entry 3

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,194,710

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $556.03 to $557.02, inclusive.

Read SEC document
August 31, 2023 Filed Sep 1, 2023 20:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 8,306 $555.35 $4,612,745.41
Disclosure

SEC source: 0001415889-23-012859 · form4-09012023_040902.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,199,151

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $555.00 to $555.97, inclusive.

Read SEC document
August 31, 2023 Filed Sep 1, 2023 20:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 32,894 $554.38 $18,235,611.25
Disclosure

SEC source: 0001415889-23-012859 · form4-09012023_040902.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,207,457

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $554.00 to $554.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3) and (4) to this Form 4.

Read SEC document
August 30, 2023 Filed Aug 31, 2023 20:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 900 $557.36 $501,621.30
Disclosure

SEC source: 0001415889-23-012835 · form4-08312023_040801.xml · nonDerivative · entry 4

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,240,351

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $557.06 to $557.57, inclusive.

Read SEC document
August 30, 2023 Filed Aug 31, 2023 20:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 456 $556.13 $253,595.28
Disclosure

SEC source: 0001415889-23-012835 · form4-08312023_040801.xml · nonDerivative · entry 3

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,241,251

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $556.02 to $556.25, inclusive.

Read SEC document
August 30, 2023 Filed Aug 31, 2023 20:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 3,000 $555.28 $1,665,846.00
Disclosure

SEC source: 0001415889-23-012835 · form4-08312023_040801.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,241,707

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $555.01 to $555.83, inclusive.

Read SEC document
August 30, 2023 Filed Aug 31, 2023 20:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 1,825 $554.17 $1,011,354.78
Disclosure

SEC source: 0001415889-23-012835 · form4-08312023_040801.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,244,707

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $554.00 to $554.59, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3) and (4) to this Form 4.

Read SEC document
August 29, 2023 Filed Aug 30, 2023 20:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 300 $555.85 $166,755.00
Disclosure

SEC source: 0001415889-23-012799 · form4-08302023_040804.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,246,532

Read SEC document
August 29, 2023 Filed Aug 30, 2023 20:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 28,447 $554.08 $15,761,942.21
Disclosure

SEC source: 0001415889-23-012799 · form4-08302023_040804.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,246,832

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $554.00 to $554.97, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

Read SEC document
August 28, 2023 Filed Aug 29, 2023 20:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 500 $555.54 $277,770.00
Disclosure

SEC source: 0001415889-23-012748 · form4-08292023_040801.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,275,279

Read SEC document
August 28, 2023 Filed Aug 29, 2023 20:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 37,160 $554,101.00 $20,590,393,160.00
Disclosure

SEC source: 0001415889-23-012748 · form4-08292023_040801.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,275,779

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $554.00 to $554.98, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

Read SEC document
August 25, 2023 Filed Aug 28, 2023 20:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 300 $556.06 $166,818.00
Disclosure

SEC source: 0001415889-23-012716 · form4-08282023_040801.xml · nonDerivative · entry 3

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,312,939

Read SEC document
August 25, 2023 Filed Aug 28, 2023 20:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 8,527 $555.39 $4,735,810.53
Disclosure

SEC source: 0001415889-23-012716 · form4-08282023_040801.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,313,239

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $555.00 to $555.95, inclusive.

Read SEC document
August 25, 2023 Filed Aug 28, 2023 20:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 54,745 $554.22 $30,340,609.67
Disclosure

SEC source: 0001415889-23-012716 · form4-08282023_040801.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,321,766

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $554.00 to $554.965, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.

Read SEC document
August 24, 2023 Filed Aug 25, 2023 20:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 3,300 $556.34 $1,835,912.10
Disclosure

SEC source: 0001415889-23-012661 · form4-08252023_040801.xml · nonDerivative · entry 3

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,376,511

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $556.065 to $556.47, inclusive.

Read SEC document
August 24, 2023 Filed Aug 25, 2023 20:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 1,400 $555.75 $778,054.20
Disclosure

SEC source: 0001415889-23-012661 · form4-08252023_040801.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,379,811

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $555.02 to $556.00, inclusive.

Read SEC document
August 24, 2023 Filed Aug 25, 2023 20:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 16,292 $554.33 $9,031,062.90
Disclosure

SEC source: 0001415889-23-012661 · form4-08252023_040801.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,381,211

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $554.00 to $554.91, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4.

Read SEC document
August 23, 2023 Filed Aug 24, 2023 20:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 1,307 $555.69 $726,284.48
Disclosure

SEC source: 0001415889-23-012600 · form4-08242023_040801.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,397,503

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $555.33 to $556.165, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

Read SEC document
August 15, 2023 Filed Aug 16, 2023 20:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 3,961 $546.73 $2,165,605.45
Disclosure

SEC source: 0001415889-23-012311 · form4-08162023_040802.xml · nonDerivative · entry 9

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,398,810

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $546.44 to $547.12, inclusive.

Read SEC document
August 15, 2023 Filed Aug 16, 2023 20:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 12,366 $545.98 $6,751,576.31
Disclosure

SEC source: 0001415889-23-012311 · form4-08162023_040802.xml · nonDerivative · entry 8

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,402,771

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $545.44 to $546.42, inclusive.

Read SEC document
August 15, 2023 Filed Aug 16, 2023 20:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 12,698 $544.90 $6,919,178.29
Disclosure

SEC source: 0001415889-23-012311 · form4-08162023_040802.xml · nonDerivative · entry 7

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,415,137

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $544.44 to $545.43, inclusive.

Read SEC document
August 15, 2023 Filed Aug 16, 2023 20:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 7,223 $544.01 $3,929,377.01
Disclosure

SEC source: 0001415889-23-012311 · form4-08162023_040802.xml · nonDerivative · entry 6

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,427,835

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $543.435 to $544.43, inclusive.

Read SEC document
August 15, 2023 Filed Aug 16, 2023 20:00 UTC ELI LILLY & Co LLY · Entity 2794 SaleCommon Stock 2,100 $543.08 $1,140,463.80
Disclosure

SEC source: 0001415889-23-012311 · form4-08162023_040802.xml · nonDerivative · entry 5

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,435,058

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $542.43 to $543.39, inclusive.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.